Question 1

What does Union Chimique Belge do?

Accepted Answer

UCB is a biopharma company that focuses on the research and development of medication for neurology and immunology diseases.

Question 2

In what sectors does Union Chimique Belge operate?

Accepted Answer

Union Chimique Belge operates in Biotechnology, Health Care, Pharmaceutical.

Question 3

How many companies has Union Chimique Belge acquired?

Accepted Answer

Union Chimique Belge has made 13 acquisitions between 2004-2026, with a total disclosed deal value of $7.0B.

Question 4

What companies are owned by Union Chimique Belge?

Accepted Answer

Companies acquired by Union Chimique Belge include Candid Therapeutics, IMIDomics-Patient Insight Business, Neurona Therapeutics, Zogenix, Handl Therapeutics, Engage Therapeutics, Ra Pharmaceuticals, Element Genomics, and 5 more.

Question 5

What are Union Chimique Belge's major acquisitions?

Accepted Answer

Union Chimique Belge's largest acquisitions include Ra Pharmaceuticals ($2.1B, 2019), Candid Therapeutics ($2.0B, 2026), Zogenix ($1.9B, 2022), Neurona Therapeutics ($650.0M, 2026).

Question 6

What is Union Chimique Belge's largest acquisition?

Accepted Answer

Union Chimique Belge's largest disclosed acquisition is Ra Pharmaceuticals for $2.1B (2019).

Question 7

What was Union Chimique Belge's first acquisition?

Accepted Answer

Union Chimique Belge's first recorded acquisition was Celltech Therapeutics in 2004.

Question 8

What was Union Chimique Belge's most recent acquisition?

Accepted Answer

Union Chimique Belge's most recent acquisition is Candid Therapeutics, announced May 2026 for $2.0B.

Question 9

What is the average deal size for Union Chimique Belge acquisitions?

Accepted Answer

The average disclosed deal size for Union Chimique Belge acquisitions is $993.7M.

Question 10

What is the median deal size for Union Chimique Belge acquisitions?

Accepted Answer

The median disclosed deal size for Union Chimique Belge acquisitions is $650.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Union Chimique Belge spent on acquisitions?

Accepted Answer

Union Chimique Belge has spent at least $7.0B across its disclosed acquisitions (of 13 total deals; some prices are undisclosed).

Question 12

Which sector has Union Chimique Belge spent the most on?

Accepted Answer

Union Chimique Belge has committed the most disclosed capital to Biotechnology companies — about $7.0B across its deals in that sector.

Question 13

What sectors does Union Chimique Belge usually acquire in?

Accepted Answer

Union Chimique Belge most frequently acquires companies in Biotechnology, Health Care, Pharmaceutical.

Question 14

In which sector has Union Chimique Belge made the most acquisitions?

Accepted Answer

Union Chimique Belge has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Union Chimique Belge make the most acquisitions?

Accepted Answer

Union Chimique Belge made the most acquisitions in 2026, with 3 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Union Chimique Belge

Company Details

Funding & Financials

Web Traffic

Investor Activity

Company Info

Investments by Union Chimique Belge

Acquisitions by Union Chimique Belge

Key People at Union Chimique Belge

Explore 200,000+ acquisitions — free

Recent News related to Union Chimique Belge

FAQs about Union Chimique Belge

People who checked this page also checked these